期刊文献+

自播散疫苗

Self-disseminating vaccines
下载PDF
导出
摘要 自播散疫苗(Self-disseminating vaccines,SDV)是一种携带抗原编码基因的可复制病毒载体,不但能免疫被接种动物,并能在被接种动物体内复制后再感染与被接种动物接触的动物使其被免疫。黏液瘤病毒是第一个被发现的SDV病毒载体,被成功用于预防兔多发黏液瘤病。由于具有独特的性质,巨细胞病毒(Cytomegalovirus,CMV)可能成为理想的研制SDV的载体。动物源性新发传染病(如埃博拉病毒病等)的不断出现正促进SDV的研制。SDV可能成为一种能有效阻断新发传染病病原体从动物向人传播的生物制品。 Self-disseminating vaccines( SDV) is a type of replicating virus-based vectors carrying encoding genes of protective antigens from pathogenic microorganisms. The SDV is able to replicate in the immunized animals,and afetrwards to be disseminated from the immunized animals to nave animals to contact with them. The myxoma virus was the first viral vector used in SDV for the prevention of myxomatosis in wild rabbits. Due to its unique characteristics,cytomegalovirus( CMV)has been investigated as an ideal vector for developing SDV. The need for developing SDV has been emphasized by the increased rate of emerging infectious diseases( EID),such as Ebola virus disease. SDV should be a novel approach to potentially interrupt transmission of the pathogens causing EID from animal to human( zoonotic).
作者 于永利
出处 《微生物学免疫学进展》 2016年第4期1-6,共6页 Progress In Microbiology and Immunology
关键词 自播散疫苗 可复制病毒载体 巨细胞病毒 新发传染病 埃博拉病毒病 Self-disseminating vaccines Replicating virus-based vector Cytomegalovirus Emerging infectious diseases(EID) Ebola virus disease
  • 相关文献

参考文献40

  • 1Murphy AA,Redwood AJ,Jarvis MA.Self-disseminating vaccines for emerging infectious diseases[J].Expert Rev Vaccines,2016,15(1):31-39.
  • 2Bárcena J,Morales M,Vázquez B,et al.Horizontal transmissible protection against myxomatosis and rabbit hemorrhagic disease by using a recombinant myxoma virus[J].J Virol,2000,74(3):1114-1123.
  • 3Bárcena J,Pagès-MantéA,March R,et al.Isolation of an attenuated myxoma virus field strain that can confer protection against myxomatosis on contacts of vaccinates[J].Arch Virol,2000,145(4):759-771.
  • 4Spiesschaert B,Mc Fadden G,Hermans K,et al.The current status and future directions of myxoma virus,a master in immune evasion[J].Vet Res,2011,42:76.
  • 5Knipe DM,Howley PM.Fields virology[M].Philadelphia:Lippincott-Raven Publishers,2007:2701-2772.
  • 6Marzi A,Murphy AA,Feldmann F,et al.Cytomegalovirus-based vaccine expressing Ebola virus glycoprotein protects nonhuman primates from Ebola virus infection[J].Sci Rep,2016,6:21674.
  • 7Rizvanov AA,van Geelen AG,Morzunov S,et al.Generation of a recombinant cytomegalovirus for expression of a hantavirus glycoprotein[J].J Virol,2003,77(22):12203-12210.
  • 8Rizvanov AA,Khaiboullina SF,van Geelen AG,et al.Replication and immunoactivity of the recombinant peromyscus maniculatus cytomegalovirus expressing hantavirus G1 glycoprotein in vivo and in vitro[J].Vaccine,2006,24(3):327-334.
  • 9Deere JD,Barry PA.Using the nonhuman primate model of HCMV to guide vaccine development[J].Viruses,2014,6(4):1483-1501.
  • 10Anoh AE,Akoua-Koffi C,Couacy-Hymann E.et al.Genetic identification of cytomegaloviruses in a rural population of Cte d'Ivoire[J].Virol J,2015,12:155.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部